1. Home
  2. BOX vs AMRX Comparison

BOX vs AMRX Comparison

Compare BOX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$24.64

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$11.91

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
AMRX
Founded
2005
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
BOX
AMRX
Price
$24.64
$11.91
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$35.57
$14.75
AVG Volume (30 Days)
2.4M
1.9M
Earning Date
03-03-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
0.58
0.22
Revenue
$506,142,000.00
N/A
Revenue This Year
$9.41
$6.40
Revenue Next Year
$8.15
$6.54
P/E Ratio
$42.51
$53.66
Revenue Growth
26.98
N/A
52 Week Low
$21.61
$6.69
52 Week High
$38.80
$15.42

Technical Indicators

Market Signals
Indicator
BOX
AMRX
Relative Strength Index (RSI) 49.56 31.31
Support Level $23.70 $11.55
Resistance Level $33.30 $12.12
Average True Range (ATR) 0.77 0.44
MACD 0.05 -0.11
Stochastic Oscillator 29.13 8.92

Price Performance

Historical Comparison
BOX
AMRX

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: